SAVA Stock Analysis: Buy, Sell, or Hold?
SAVA - Cassava Sciences, Inc.
$2.38
0.26 (12.26%)
â˛
5d:
+7.21%
30d:
+17.24%
90d:
-26.99%
WAIT
LOW Confidence
Analysis Updated: Mar 10, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SAVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SAVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SAVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SAVA is currently trading at $2.38, which is considered fair based on recent price action.
Technical Outlook: Technically, SAVA is in a strong downtrend. Immediate support is located at $1.96, while resistance sits at $2.49. The stock is showing strong short-term momentum, up 12.3% recently.
Market Sentiment: SAVA scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.00 (+236.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SAVA is in a strong downtrend. Immediate support is located at $1.96, while resistance sits at $2.49. The stock is showing strong short-term momentum, up 12.3% recently.
Market Sentiment: SAVA scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.00 (+236.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: Strong upward momentum (+12.3%)
- BULLISH: Trading 236.1% below Wall St target ($8.00)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$1.96
Resistance Level
$2.49
Current Trend
Strong Downtrend
Technical data as of
Mar 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.95
Wall Street Target
$8.00
(+236.1%)
Share & Embed Analysis
Last updated: August 24, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SAVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
